Key Highlights

• OCA shares declined 8.27% to $0.61 on 9 September 2026 amid broader market pressure.

• A limited on-market share buyback of up to 3.5 million shares over 12 months was approved on 31 July 2026.

• The buyback is specifically designed to offset dilution from the vesting of restricted share rights and share option employee Equity plans.

• Shares bought back will be cancelled immediately upon acquisition; Buybacks will occur on the NZX Main Board only, not ASX.

Shares in Oceania Healthcare Ltd (ASX:OCA) fell 8.27% to $0.61 on 9 September 2026, extending recent weakness as the broader market tone weighed on the stock. Today, S&P/ASX 200 Health Care [XHJ] index closed 1.50% down. The company, dual-listed on both the NZX and ASX, made a limited corporate announcement in late July relating to a modest share buyback programme designed to manage the dilutionary impact of its employee equity plans — a structural Capital management measure rather than a signal of any major corporate development.

Buyback Programme: Structure and Intent

On 31 July 2026, Oceania Healthcare's Board of Directors approved a limited on-market share buyback of up to 3.5 million shares to be executed over the following 12 months. The buyback will be conducted through the NZX Main Board order-matching market and shares acquired will be cancelled immediately upon purchase. The programme will not involve any buyback activity through the ASX.

The stated purpose of the buyback is specific and limited: to avoid diluting existing shareholders through the additional share issuance that would otherwise accompany the vesting of restricted share rights or the exercise of share Options under Oceania's employee equity plans. In this context, the buyback is a capital management tool designed to keep the share count broadly neutral relative to the employee equity program, rather than a broader market repurchase or Shareholder return initiative.

Vesting Activity and Buyback Timing

Oceania issued 120,740 shares on 28 July 2026 in connection with employee equity plan entitlements and indicated that it planned to buy back an equivalent number of shares on or from 5 August 2026. The company indicated that further shares may be bought back on or about the time that other employee equity plan entitlements are exercised or vest, subject to the company being satisfied at the relevant time that it does not hold material non-public information. This conditional nature of buyback execution reflects the company's commitment to Insider Trading compliance in managing the timing of share repurchases.

The maximum number of quoted ordinary shares to be acquired under the programme will not exceed 3.5 million in the 12-month period from the 31 July 2026 announcement date. In the context of Oceania's total share count, this cap represents a modest proportion of Issued Capital and is sized specifically to offset employee equity dilution rather than to support the share price through large-scale market buying.

Regulatory Disclosure and NZX Listing Rule Compliance

For the purposes of NZX Listing Rule 4.14.2, Oceania provided the required disclosures, including that shares will be bought back on or from 5 August 2026 and may continue from time to time up until the 12-month anniversary of the announcement date, and that the maximum number of shares to be acquired will not exceed 3.5 million in that period. The programme was authorised for release by Sarah Miller, Chief Legal and Corporate Services Officer and Company Secretary.

Oceania Healthcare operates across the residential aged care and retirement village sectors in New Zealand. The company's financial and operational performance metrics, beyond the scope of this announcement, will be the primary driver of the stock's medium-term trajectory. Investors focused on the New Zealand aged care sector will be looking to the company's next financial result update for indicators of occupancy trends, development activity and Margin performance.

Conclusion

The 8.27% decline in Oceania Healthcare's share price on 9 September 2026 appears to reflect broader market conditions rather than any new adverse development specific to the company. The limited share buyback programme announced in late July is a routine capital management measure with a defined and modest scope. For investors, the primary focus points remain the company's operational performance in the New Zealand aged care and retirement village sectors, where occupancy levels, development pipeline progress and Interest Rate sensitivity are the key variables to monitor.